INTRODUCTION {#s1}
============

Budding yeast Mec1 belongs to the conserved ATM/ATR family of signal transducers involved in a range of processes, including DNA damage repair, checkpoint response, cell cycle regulation, and meiosis ([@BIO015347C17]; [@BIO015347C37]; [@BIO015347C1]; [@BIO015347C6]). In addition, Mec1 and its mammalian counterpart ATR, are essential during unperturbed proliferation, whereby their inactivation leads to permanent DNA replication block followed by a fatal mitotic catastrophe in the respective organism ([@BIO015347C5]; [@BIO015347C7]; [@BIO015347C8]; [@BIO015347C12]).

The replication block in *mec1* cells was proposed to stem from a defect in the Mec1-Rad53-Dun1 dependent removal of Sml1 at the onset of S phase ([@BIO015347C40][@BIO015347C41]; [@BIO015347C39]). Sml1 is an inhibitor of the ribonucleotide reductase (RNR), which catalyses the rate limiting step in dNTP synthesis ([@BIO015347C11]; [@BIO015347C40][@BIO015347C41]; [@BIO015347C39]). Rad53, a homolog of mammalian CHEK2, is an essential downstream effector kinase of Mec1 ([@BIO015347C3]; [@BIO015347C24]). Dun1 is another serine/threonine kinase and responsible for Sml1 phosphorylation and degradation ([@BIO015347C41]; [@BIO015347C39]). According to this view, the Mec1-Rad53-Dun1-dependent Sml1 removal and ensuing RNR activation would promote the dNTP production. In support for this view, it was shown that dNTP levels in *mec1-* or *rad53-*hypomorphs and a *dun1*Δ strain were reduced by as much as 46% compared to a *MEC1* control strain ([@BIO015347C41]; [@BIO015347C13]; [@BIO015347C15]).

Notably, however, nearly all analyses on a lethal *mec1* allele \[e.g. *mec1*Δ or *mec1-kd* (kinase dead)\] have been performed in a strain background that was either deleted for *SML1* or over-expressing *RNR1*, a requirement for maintaining viability of a mutant lacking Mec1\'s essential function (e.g. [@BIO015347C11]; [@BIO015347C40]). As a result, while it is clear that absence of Mec1 causes dNTP pool to decrease, the true extent of the reduction and whether it would be sufficient to account for the replication arrest remain elusive. Here, we addressed these questions utilizing a temperature sensitive mutant, *mec1-4,* which maintains its viability at permissive temperature in an otherwise wild-type background, circumventing the need to exogenously manipulate Sml1 and/or RNR activity ([@BIO015347C8]).

RESULTS AND DISCUSSION {#s2}
======================

We began the analysis by performing a multi-copy suppressor screen for *mec1-4* ([Fig. S1](Fig. S1)). The screen identified *GIS2* (glucose inhibition of gluconeogenic growth suppressor 2) as a novel suppressor ([Fig. 1](#BIO015347F1){ref-type="fig"}A): The only other suppressors identified were *MEC1* and *RNR1* ([Fig. S1](Fig. S1)). *GIS2* was originally isolated based its role in alternative carbon source utilization ([@BIO015347C4]). Subsequently, it was shown to encode a conserved zinc finger protein, whose orthologs include the fission yeast Byr3, identified as a negative regulator of the RAS/PKA pathway ([@BIO015347C36]) and CNBP/ZNF9, an essential mammalian protein, implicated in myotonic dystrophy type 2 ([@BIO015347C29]; [@BIO015347C20]). Fig. 1.***GIS2* suppression of *mec1* lethality and replication defect.** (A) *MEC1* or *mec1-4* strains carrying the indicated plasmids were grown at permissive temperature (23°C) to mid-log phase before being diluted to OD600 of 0.5. Ten-fold serial dilutions were spotted and incubated at the indicated temperature for two days. pCont, YEp24 plasmid; p*MEC1* or p*GIS2*, YEp24 carrying either *MEC1* or *GIS2,* respectively. (B) Log phase cultures of strains with the indicated genotypes were α-factor arrested at permissive temperature (23°C) and released into fresh YPD at 30°C. Samples were collected every 10 min and subjected to FACS analysis. The positions of 1- or 2-cell DNA content (1C or 2C) are as indicated. (C) Strains with the indicated genotypes were subjected to spot-test as described in A. '+' or '*ts*' in the *MEC1* column corresponds to *MEC1* or *mec1-4* allele, respectively. '+' or 'Δ' in the *DUN1* column corresponds to *DUN1* or *dun1*Δ allele, respectively. '+' or '−' in the *GIS2* column corresponds to p*GIS2* or pCont, respectively.

To rule out the possibility that *GIS2* was an allele specific suppressor*,* we examined its effects on a different *mec1* allele, *mec1-40*: While *mec1-4* contains a single amino acid alteration in the conserved kinase domain, *mec1-40* carries an alteration in the N-terminal HEAT (Huntington, elongation factor 3, protein phosphatase 2A, Tor1) repeat domain ([@BIO015347C27]; E. Waskiewicz and R.C., unpublished results). Introduction of a multi-copy plasmid carrying *GIS2* (p*GIS2*) also suppressed *mec1-40* temperature sensitivity*,* demonstrating that the suppression was not allele-specific ([Fig. S2A](Fig. S2A)); however, it was not able to rescue a null (*mec1*Δ) or a kinase dead (*mec1-kd*) (data not shown). Notably, *GIS2* did not rescue lethality conferred by temperature sensitive alleles of *YCG1*, *TOP2*, *ESP1* or *DBF4*, encoding for a condensin subunit, topoisomerase II, separase, or the regulatory subunit of Cdk7-Dbf4 kinase, respectively; thus, *GIS2* is not a suppressor of general temperature sensitivity ([Fig. S2B](Fig. S2B)).

To test whether the *GIS2* suppression was mediated by restoring Mec1\'s function in responding to replication stress or DNA damage, we assessed the effects of p*GIS2* on sensitivity of *mec1-4* to hydroxyurea (HU) or methyl methanesulfonate (MMS), respectively. *GIS2* did not rescue the drug sensitivity ([Fig. S2C](Fig. S2C)), suggesting that the suppression was independent of the role of Mec1 in mediating responses to HU or MMS.

The effects of *GIS2* on S phase progression were assessed. In a *MEC1* strain carrying either p*GIS2* or a control YEp24 plasmid (pCont), genome duplication was initiated and completed within 40 min following α-factor arrest/release ([Fig. 1](#BIO015347F1){ref-type="fig"}B). A *mec1-4* strain carrying pCont initiated genome duplication but failed to complete, in agreement with previous reports ([@BIO015347C8]; [@BIO015347C14]). In contrast, DNA replication in the same *mec1-4* strain carrying p*GIS2* was completed by t=40 min. We infer that the *GIS2* rescue of *mec1* lethality is mediated by promoting efficient genome duplication, thereby averting the downstream fatal mitotic catastrophe.

To test whether the *GIS2* suppression was dependent on the Mec1-Rad53-Dun1 pathway ([@BIO015347C41]; [@BIO015347C39]), we assessed the effects of *GIS2* on a *mec1-4 dun1*Δ double mutant ([Fig. 1](#BIO015347F1){ref-type="fig"}C). Deletion of *DUN1* shows synthetic growth defects with hypomorphic *mec1* mutants (e.g. [@BIO015347C39]). Similarly, we observed synthetic interaction between *DUN1* and *mec1-4,* whereby *dun1*Δ lowered restrictive temperature of a *mec1-4* strain from 30°C to 27°C ([Fig. 1](#BIO015347F1){ref-type="fig"}C). Nevertheless, p*GIS2* improved viability of a *mec1-4 dun1*Δ mutant at 27°C, indicating that the suppression did not require the Mec1-Rad53-Dun1 signalling.

Next, we assessed the effects of p*GIS2* on steady-state Sml1 levels. During unchallenged proliferation, Sml1 undergoes S-phase- and *MEC1/RAD53/DUN1-*dependent downregulation (e.g. [@BIO015347C41]). As expected, we observed a notable reduction in the Sml1 levels in a *MEC1* strain between t=10-30 and 70-90 min following an α-factor arrest/release, corresponding to the first and presumably the second round of S phase, respectively ([Fig. 2](#BIO015347F2){ref-type="fig"}; [Fig. S3](Fig. S3)). A similar S-phase-dependent reduction in Sml1 levels was observed in a *mec1-4* culture released at 23°C between t=40 and 80 min ([Fig. 2](#BIO015347F2){ref-type="fig"}). The notable delay in the timing is likely due to the lower temperature utilized to maintain viability of the mutant. The latter confirms that *mec1-4* cells are proficient in promoting the S-phase-dependent Sml1 destruction at permissive temperature. At 30°C, however, Sml1 levels in the mutant continued to increase and were maintained at high levels despite the fact that the cells were in S phase ([Fig. 2](#BIO015347F2){ref-type="fig"}; [Fig. S3](Fig. S3)). Introduction of p*GIS2* promoted efficient genome duplication in the *mec1-4* strain at 30°C ([Fig. 2](#BIO015347F2){ref-type="fig"}C). Remarkably, however, the Sml1 levels in the latter did not decrease, but increased, during genome duplication ([Fig. 2](#BIO015347F2){ref-type="fig"}). The current observation eliminates Sml1 downregulation as a mechanism underlying the *GIS2* suppression. Furthermore, it demonstrates that the replication defect following Mec1 inactivation can be decoupled from Sml1 stabilization. Fig. 2.**Effects of *GIS2* on S phase progression and cell-cycle-dependent fluctuation in Sml1 levels.** (A) Strains with the indicated genotypes were α-factor arrested at 23°C and released into fresh YPD at either 23°C or 30°C. Western blot analysis using an α-MYC antibody was performed to detect MYC-Sml1. \* indicates non-specific band used as a loading control; N, no-tag control sample. (B) The amounts of 3MYC-Sml1 in the western blots were quantified and normalised to the non-specific band (\*) in the corresponding lane. These values were normalised to the value at t=0 ('αF') in each culture as a means to assess cell cycle dependent fluctuation in Sml1 levels. (C) Results of FACS analysis on samples analysed in A, *WT* corresponds to *MEC1*, *ts* corresponds to *mec1-4*, *ts*+p*GIS2* corresponds to *mec1-4*+p*GIS2*.

To test whether the *GIS2* suppression might be mediated by an increase in RNR activity, we assessed its effects on *RNR1* transcription induction at the onset of S phase ([Fig. 3](#BIO015347F3){ref-type="fig"}A). In all strains, the level of *RNR1* transcripts following α-factor arrest/release peaked at the first time point, t=10 min. The levels in the WT and *mec1-4*+p*GIS2* strains gradually decreased back to the basal level by 40 min ([Fig. 3](#BIO015347F3){ref-type="fig"}A), coinciding with the completion of bulk genome duplication in these cultures ([Fig. 1](#BIO015347F1){ref-type="fig"}B). Importantly however, p*GIS2* did not increase the level or duration of *RNR1* mRNA induction the *mec1-4* culture ([Fig. 3](#BIO015347F3){ref-type="fig"}A). We also assessed effects of p*GIS2* on levels of Rnr1 protein as well as *RNR2*, *3*, and *4* transcripts, where no noticeable difference was observed ([Fig. 3](#BIO015347F3){ref-type="fig"}B; [Fig. S3](Fig. S3)). Taken together, we conclude that the *GIS2* suppression is not mediated by an increase in RNR expression. Fig. 3.**Effects of *GIS2* on levels of the *RNR1* transcripts and proteins.** (A) Effects of *GIS2* on G1/S transition-dependent *RNR1* induction. *MEC1* or *mec1-4* strains carrying either pCont or p*GIS2* were released from α-factor arrest at 23°C into fresh YPD at 30°C. Samples were collected and subjected to FACS ([Fig. 1](#BIO015347F1){ref-type="fig"}B) and northern blot analysis (upper panel) using *RNR1* as probe. *ACT1*, encoding actin, is used as a loading control. Lower panel: the *RNR1* signals were quantified and normalized to the *ACT1* signal in corresponding sample. For each strain, the normalized values were then expressed relative to the values obtained for the α-factor sample, which was set to 1. The average of two independent experiments is shown. The error bars show ±s.e.m. (B) Effects of *GIS2* on steady state Rnr1-HA levels. *MEC1* or *mec1-4* strains carrying either pCont or p*GIS2* were grown to mid-log phase at 23°C before being shifted to 30°C for four hours. Upper panel: western blot analysis was performed using an α-HA and an α-tubulin antibodies. Lower panel: average levels of the HA-Rnr1 protein, normalized to the tubulin loading control, and calculated from four independent experiments. The error bars show ±s.e.m.

In yeast, additional mechanisms of controlling dNTP production exist; for example, the dATP feedback inhibition of RNR and regulation of Rnr1, 2, 3, and 4 sub-cellular localization ([@BIO015347C9]; [@BIO015347C38]; [@BIO015347C19]). Instead of testing potential involvement of each of these mechanisms, we decided to directly assess the effects of *GIS2* on dNTP pools. Following a temperature shift from 23°C to 30°C, both *MEC1* and *mec1-4* cultures exhibited a transient reduction in the dNTP levels followed by a recovery ([Fig. 4](#BIO015347F4){ref-type="fig"}A). The dNTP levels in a *mec1-4* strain transformed with pCont were reduced to ∼83% of a *MEC1* control strain ([Fig. 4](#BIO015347F4){ref-type="fig"}B). Ectopic expression of *GIS2* led to an increase; however, the extent was limited, restoring dNTP levels to only ∼93% of the control. Thus, the replication arrest and its rescue conferred by Mec1 inactivation and *GIS2,* respectively, are both accompanied by unexpectedly modest changes in dNTP levels. The current observations are reminiscent of a *rad53* allele lacking key Mec1 phosphorylation sites, which was similarly shown to reduce dNTP pool by only ∼15% ([@BIO015347C15]). Fig. 4.**Steady state dNTP levels in *MEC1* and *mec1-4* strains carrying pCont or p*GIS2*.** (A,B) Strains of the indicated genotypes were grown to mid-log phase at 23°C before being shifted to 30°C. Samples were collected at the specified times and analysed for levels of dATP, dCTP, dGTP, and dTTP. Shown in B are the total dNTP concentrations in each sample. For concentrations of each dNTP, see panel C and [Fig. S5](Fig. S5). All strains are in a SK1 background except for the 'Control', which is a *MEC1* strain in a W303 background. (C) Concentration of each of the four dNTPs in *MEC1* and *mec1-4* following a shift to 30°C.

dNTP levels in *mec1-* or *rad53-*hypomorphs, or a *dun1*Δ can be reduced by as much as 46% of a control ([@BIO015347C41]; [@BIO015347C13]; [@BIO015347C15]). Notably, all of these mutants are viable, which indicates that that genome duplication is possible even when dNTP levels fall below those that we observed in *mec1-4* cells. We also found that *mec1-4* cells in a SK1 background had ∼30% higher dNTP levels compared to a *MEC1* strain in a different genetic background of a comparably sized genome (∼17 Mb), which was used as a control in the above mentioned *mec1-/rad53-* hypomorph studies ([Fig. 4](#BIO015347F4){ref-type="fig"}B; 390 pmoles vs 296 pmoles/10^8^ cells). Taken together these observations strongly suggest that the dNTP pool in a *mec1-4* strain would have been sufficient to support genome duplication under normal condition, and therefore was unlikely to be the sole cause of the arrest. The ratio among four different dNTPs in *mec1-4* was comparable to *MEC1* ([Fig. 4](#BIO015347F4){ref-type="fig"}C), ruling out the possibility that the replication block is due to imbalance in dNTP precursors ([@BIO015347C18]).

To the best of our knowledge, these are the first direct dNTP pool measurements in a strain expressing a lethal *mec1* allele without altering Sml1 or RNR activity. While the results confirm a Mec1\'s role in promoting dNTP synthesis, they reveal that loss of this function is unlikely to be a direct cause of the *mec1* replication arrest. To date, ∼80 direct targets of Mec1 have been identified. They include components of the RPA complex (Rfa1 and Rfa2; [@BIO015347C34]), the GINS complex (Psf1; [@BIO015347C10]), and the MCM-helicase complex (Mcm4 and Mcm6; [@BIO015347C30]), all of which are directly involved in DNA replication. Therefore, inactivation of Mec1 might result in a system-wide failure in genome duplication stemming from inability to phosphorylate key components of the replication machinery. Under such condition, DNA replication might become acutely sensitive to dNTP levels, whereby even a modest reduction in dNTP pool, which would not impair normal genome duplication, triggers a permanent arrest.

Most known suppressors of *mec1* lethality are involved in dNTP synthesis or its regulation (e.g. [@BIO015347C11]; [@BIO015347C40]; [@BIO015347C35]). In yeast, the rate of replication fork progression correlates with the dNTP pool size ([@BIO015347C22]; [@BIO015347C31]; [@BIO015347C25]; [@BIO015347C28]). Furthermore, elevated levels of dNTP can promote fork progression through DNA lesions that normally block its progression ([@BIO015347C22]; [@BIO015347C31]; [@BIO015347C25]; [@BIO015347C28]). These observations suggest that *GIS2* suppression of *mec1-4* acts also via its effects on dNTP levels. Gis2 regulates protein levels of several hundred target mRNAs that are enriched in ribosome assembly, chromatin structure, GTPase activity, and stress signalling ([@BIO015347C32]; [@BIO015347C33]). However, none of the well-known components of the Mec1 signalling network (e.g. *SML1*, *DUN1*, *RNR1-4*, *HUG1*, *DIF1*, *RAD53*, *RAD9*, or *TEL1*) is targeted by Gis2. Therefore, the mechanism underlying the *GIS2-*dependent dNTP pool increase is likely to be pleiotropic and indirect.

Current observations are reminiscent of the effects of dNTPs on mammalian genome duplication, in particular, with regard to oncogene-induced replication stress: It was shown that many consequences of the stress (e.g. DNA damage, fragile site expression, genome instability, and/or cell death) can be either exacerbated or rescued by changes in dNTP levels ([@BIO015347C2]; [@BIO015347C23]; [@BIO015347C26]; [@BIO015347C21]). Evidence presented above provides a fresh insight into the phenomenon that even a modest change in dNTP availability could result in a profound consequence.

MATERIALS AND METHODS {#s3}
=====================

Yeast strains and media {#s3a}
-----------------------

All strains were of the SK1 background unless noted ([Table S1](Table S1)). Hydroxylamine mutagenesis of *MEC1* and isolation of the temperature sensitive *mec1-4* allele were previously described ([@BIO015347C8]). Multi-copy suppressor screen for *mec1-4* is described in [Fig. S1](Fig. S1). To obtain a synchronous culture for cell cycle analysis, cultures grown to mid-log phase at 23°C (permissive temperature for *mec1-4*) were arrested with 5 µg/ml α-factor for 3 h before being released to fresh YPD \[1% (w/v) yeast extract, 2% (w/v) bacto-peptone, 2% (w/v) glucose\] media at the indicated temperature.

Fluorescence activated cell scan (FACS) analysis {#s3b}
------------------------------------------------

Cells were fixed \[40% (v/v) ethanol, 0.1 M sorbitol\] for 3 h and incubated overnight at 37°C with RNase solution (50 mM Tris-HCl pH 7.5, 100 µg/ml RNaseA). The next day, the cells were treated with 500 µl of pepsin solution (50 mM HCl, 5 mg/ml pepsin) for 5 min or longer at room temperature being resuspended in 1 ml SYTOX solution (50 mM Tris-HCl pH 7.5, 1 µM SYTOX Green; Invitrogen, Molecular Probe). After an overnight incubation at 4°C, samples were analysed on a Becton Dickinson Flow Cytometer ([@BIO015347C14]).

Western blotting and antibodies {#s3c}
-------------------------------

Whole cell extracts from ∼10^7^--10^8^ cells were prepared from cell suspensions in 20% tricholoroacetic acid (TCA) by agitation with glass beads. Precipitated proteins were solubilized in SDS-PAGE sample butter and analysed by SDS-PAGE and western blotting. Antibodies for western blotting were mouse monoclonal α-HA (1:1000; NIMR, London, UK), α-MYC (1:1000; NIMR, London, UK), and rat monoclonal α-tubulin (1:5000; Abcam).

Measurement of dNTP levels {#s3d}
--------------------------

NTP and dNTP extraction and quantification were performed as described ([@BIO015347C16]).

We thank Lisette Marjavaara for technical assistance.

**Competing interests**

The authors declare no competing or financial interests.

**Author contributions**

C.E., S.R., G.M., A.C and R.S.C. designed the experiments; C.E., S.R. and G.M. performed the experiments; C.E., G.M., A.C and R.S.C. interpreted the results. A.C and R.S.C. prepared the manuscript; C.E. and R.S.C. prepared figures and graphs; R.S.C. coordinated the study.

**Funding**

This work was funded by Medical Research Council (UK) program grant number \[U.1175.01.005.00005.01\], North West Cancer Research (UK) grant number \[RC961\], and Bangor University to R.S.C. and the Swedish Cancer Society and the Swedish Research Council funding to A.C.

**Supplementary information**

Supplementary information available online at <http://bio.biologists.org/lookup/suppl/doi:10.1242/bio.015347/-/DC1>
